These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6374488

  • 1. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
    Casanueva FF, Villanueva L, Peñalva A, Cabezas-Cerrato J.
    Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
    [Abstract] [Full Text] [Related]

  • 2. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA, Sherman BM.
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [Abstract] [Full Text] [Related]

  • 3. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
    Willoughby JO, Menadue M, Jervois P.
    Brain Res; 1982 Oct 14; 249(2):291-9. PubMed ID: 6291713
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.
    Altomonte L, Zoli A, Alessi F, Ghirlanda G, Manna R, Greco AV.
    Horm Res; 1987 Oct 14; 27(4):190-4. PubMed ID: 3436616
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Naloxone reduces the fenfluramine-induced prolactin release in man.
    Foresta C, Scanelli G, Indino M, Federspil G, Scandellari C.
    Clin Endocrinol (Oxf); 1985 Apr 14; 22(4):539-43. PubMed ID: 3987071
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat.
    Lumpkin MD, Samson WK, McCann SM.
    Endocrinology; 1983 May 14; 112(5):1711-7. PubMed ID: 6403333
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone- and prolactin-secretion in the rat.
    Koenig J, Mayfield MA, Coppings RJ, McCann SM, Krulich L.
    Brain Res; 1980 Sep 22; 197(2):453-68. PubMed ID: 6105900
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
    Van de Kar LD, Urban JH, Richardson KD, Bethea CL.
    Neuroendocrinology; 1985 Oct 22; 41(4):283-8. PubMed ID: 2931613
    [Abstract] [Full Text] [Related]

  • 18. Adrenergic and dopaminergic control of growth hormone secretion in urethan anesthetized adult male rats.
    Ruch W, Marbach P, Jaton AL, Bucher B, Doepfner W.
    Horm Res; 1978 Oct 22; 9(4):208-24. PubMed ID: 669571
    [Abstract] [Full Text] [Related]

  • 19. Activation of 5-HT 1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanaesthetized rat.
    Willoughby JO, Menadue MF, Liebelt HJ.
    Neuroendocrinology; 1988 Jan 22; 47(1):83-7. PubMed ID: 3340274
    [Abstract] [Full Text] [Related]

  • 20. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
    Mota A, Bento A, Peñalva A, Pombo M, Dieguez C.
    J Clin Endocrinol Metab; 1995 Jun 22; 80(6):1973-7. PubMed ID: 7775648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.